BioSight
Companies
Relay Therapeutics, Inc. logo

RLAY

NASDAQCAMBRIDGE, MA
Relay Therapeutics, Inc.

Relay Therapeutics develops drug candidates using protein dynamics technology to target disease-causing proteins. The company is in early-stage clinical development, having not yet completed any large-scale pivotal trials, and is exploring multiple therapeutic areas though specific programs are not detailed in this excerpt.

Price history not yet available for RLAY.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar